Kolexia
Durand Sarah
Pharmacien
Asdia Site Toul
Toul, France
37 Activités
194 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Carcinome hépatocellulaire Tumeurs du foie Hépatite B Carcinomes Maladies virales Hépatite C chronique Cirrhose du foie

Industries

Weleda S.A.
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
Science translational medicine   21 décembre 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
Journal of hepatology   27 octobre 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation.
JCI insight   08 juillet 2022
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Nature communications   17 septembre 2021
Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma.
Life science alliance   21 juillet 2021
Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.
Scientific reports   29 juillet 2020
A human liver cell atlas reveals heterogeneity and epithelial progenitors.
Nature   10 juillet 2019
Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.
Gut   10 mai 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.
Gastroenterology   09 avril 2019
An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion.
Antiviral research   30 décembre 2018